NEW STRATEGIES IN AIT BIOMARKERS BASED ON METABOLOMICS. Dr. Domingo Barber Director IMMA Universidad CEU San Pablo
|
|
- Leonard Aldous Miles
- 5 years ago
- Views:
Transcription
1 NEW STRATEGIES IN AIT BIOMARKERS BASED ON METABOLOMICS Dr. Domingo Barber Director IMMA Universidad CEU San Pablo
2 Disclosure In relation to this presentation, I declare the following, real or perceived conflicts of interest: Type Employment full time / part time Spouse / Family member employment / engagement Research Grant (P.I., collaborator or consultant; pending and received grants) Other research support Speakers Bureau / Honoraria Ownership interest (stock, stockoptions, patent or intellectual property) Consultant / advisory board Company None None None None None None ALK, AIMMUNE A conflict of interest is any situation in which a speaker or immediate family members have interests, and those may cause a conflict with the current presentation. Conflicts of interest do not preclude the delivery of the talk, but should be explicitly declared. These may include financial interests (e.g. owning stocks of a related company, having received honoraria, consultancy fees), research interests (research support by grants or otherwise), organisational interests and gifts. EAACI dedicated to Allergy Science, committed to your Health 2
3 Translational Research Allergy 2018 Submitted Clarification of pathophysiology 1 Clinical knowledge Electronic health records Clinical research 2 Epigenetics Exposomics Allergomics Genomics Epidemiology Transcriptomics Immunology Metabolomics Clinical signs and symptoms Microbiomics Prediction of prognosis Identification of biomarkers Facilitation of diagnosis 3 Individualized treatment
4 Allergy 2018 Submitted
5 COST 100 Therapeutic options in Allergy 10 1 Disease Severity Symptomatics Specific Immunotherapy Biologics EAACI dedicated to Allergy Science, committed to your Health
6 Why we need new biomarker strategies? -Biomarkers more closed to disease expression -Biomarkers that can be used to compare different intervention strategies -Biomarkers that provided evidence of the value of specific allergy intervention EAACI dedicated to Allergy Science, committed to your Health 6
7 HOW SIT WORKS?
8 Immunological response to SLIT Results at 2 years
9 EAACI dedicated to Allergy Science, committed to your Health
10 Sistemic intevention effects are expected afer 3 years Varona et al, Allergy 2018
11
12 Duration of IT is critical for sustained effect
13
14 December 08, 2003 Glaxo Chief On Drug Efficacy Allen Roses comments MOLECULAR in public on the statistics regarding pharmaceutical response rates. PROFILES "The vast majority of drugs - more than 90 per cent - only work in 30 or 50 per cent of the people," Dr Roses said. "I wouldn't say that most drugs don't work. I would say that most drugs work in 30 to 50 per cent of people. Drugs out there on the market work, but they don't work in everybody."
15 Metabolomics Definition. The study of the metabolites present within an organism, cell, tissue Metabolites are the ending / intermediate molecules from the metabolism Our phenotype could be described by the collection of metabolites and their levels in our organism Any pathology will result in specific alterations of some metabolites These can be potential biomarkers of diagnosis, prognosis or targets for pharmaceutical treatment EAACI dedicated to Allergy Science, committed to your Health 15
16 Work-Flow Hipothesis generation Analytical Validation Clinical Validation Sample Size: 20 s 100 s 1000 s Metabolites: s > Metabolic profiling analysis (non-target): Relative abundance ~100s biomarker candidates Target analysis: Accurate quantification ~10 confirmed biomarkers Other platforms (immunoassays/ microchips/ routine lab-test) Biomarkers panel Potential targets for new drug treatments
17 Metabolomics in a model of Grass Pollen Allergy Severity EAACI dedicated to Allergy Science, committed to your Health 17
18 2018
19 A Claudin1 Occludin E-cadherin IL33 R elative copy num ber Non-allergic Mild Severe P O S T N R e la tiv e c o p y n u m b e r B % a r e a % a r e a % a r e a * C D N o n -a lle r g ic M ild S e v e r e 8 0 * E F N o n -a lle r g ic M ild S e v e r e 8 0 * G 1 5 * * 2 5 * N o n -a lle r g ic M ild S e v e r e Rosace D et al, J Allergy Clin Immunol M ild S e v e r e 0 M ild S e v e r e
20 C la u d in 1 O c c lu d in e -c a d h e rin E C 5 0 to p ro filin A 1 * * * BAT correlates with Occludin loss B N o n -a lle r g ic M ild S e v e r e Non-allergic Mild Severe E C 5 0 Spearman r = P-value= Rosace D et al, J Allergy Clin Immunol 2018 (In press) E C 5 0 Spearman r = P-value= E C 5 0 Spearman r = P-value=
21 VEGFa % a r e a Masson s trichrome C o lla g e n fib e r s (% ) DAPI epithelial cells / area (pixels ) Hematoxilin & Eosin E p ith e lia l th ic k n e s s ( m ) B * * A Non-allergic Mild Severe N o n -a lle r g ic M ild S e v e r e D * * * C N o n -a lle r g ic M ild S e v e r e F * E N o n -a lle r g ic M ild S e v e r e G H * * Rosace D et al, J Allergy Clin Immunol 2018 N o n -a lle r g ic M ild S e v e r e
22 CD11c/ CD4 CD3 C D 3 + c e lls /a re a (p ix e ls ) CD11c C D 1 1 c + c e lls /a re a (p ix e ls ) A CD3/CD11c/CD4 Non-allergic Mild Severe B 8 * ** * *** C D E p C T E p C T E p * * ** C T N o n -a lle r g ic M ild S e v e r e E 0 E p C T E p C T E p C T N o n -a lle r g ic M ild S e v e r e Rosace D et al, J Allergy Clin Immunol 2018
23 Allergy In press
24 Background results. LC-MS (ESI +) OPLS- predicted model R 2 = 0.99 Q 2 = 0.75 Classes were assigned based on the prediction ecuation: Controls Mild Moderate Severe n=6 n=5 n=6 n=8 SEVERITY
25 Results ROC curve using multivariate metabolites Mild vs Moderate Using 7 metabolites EAACI dedicated to Allergy Science, committed to your Health 25
26 KEY TO UNDERSTAND UNDERLYING PROCESSES Pyruvic acid Warburg metabolism activation Lactic acid Healthy Subjects METABOLOMICS Sphingolipid metabolism stress Multiple augmented lysophospholipids Sphingosine 1-P LPC 16:0 TRANSCRIPTOMICS Altered platelet functions Adhesion Aggregation Shape Change Increasing Severity of Food Allergy Granule Secretion Vs δg αg Obeso et al Allergy. In press Severe Food Allergic Phenotype
27 SPHINGOLIPID METABOLISM ** * * Sphinganine-C17 Sphinganine-C17 analogue * ** * * Sphinganine-P Sphingosine Sphingosine-P EAACI dedicated to Allergy Science, committed to your Health 27
28 EAACI dedicated to Allergy Science, committed to your Health
29 Allergy In press
30 Role of local CpG DNA methylation in mediating the 17q21 asthma susceptibility gasdermin B (GSDMB)/ ORMDL sphingolipid biosynthesis regulator 3 (ORMDL3) expression quantitative trait locus
31 Conclusions -Omics allow a better understanding of allergy disease progression -Is possible to define a combination of biomarkers to classify patients in base to severity -This classifiction could be used to decide intervention strategies and to monitor effect -Metabolic alterations, in particular sphingosine metabolism and energy metabolism identify disease progression - Is possible to compare effect of different intervention strategies and to justify the value of specific intervention, that will be essential for ethiological management of the disease EAACI dedicated to Allergy Science, committed to your Health 31
32 Why do we need stratification? Mild -Focus on prevention Moderate: -SIT Severe: - IT poor risk/benefit - Biologics(stabilization/reverssion)
33 Acknowledgements Hospital Virgen del Puerto, Plasencia María Isabel Alvarado, MD María del Carmen Dominguez, MD Angel Vega, MD Hospital Universitario de la Princesa Carlo Blanco, MD, PhD Tania Ramon, MD Maria Teresa Belver, MD Francisco Vega, PhD Hospital Clínico San Carlos, Madrid Montserrat Fernandez-Rivas, MD, PhD Guadalupe Marco, MD, PhD Leticia Sanchez, MD Manuel de Pedro, MD HM Sanchinarro, Madrid Marcela Santaolalla, MD Mercedes Arnas, MD PI13/00477 PI15/02256 PI16/00249 ARADyAL RD16/0006/0015
34 San Pablo CEU University: IMMA Maria Escribese, PhD Domenico Rosace BSc Coral Barbas, PhD Tomas Chivato MD,PhD Juan Rodriguez-Coira BSc Alma Villaseñor, PhD David Obeso BSc Leticia Mera BSc Elisa Zubeldia BSc Marina Perez-Gordo, PhD Cristina Gomez-Casado,PhD Adoración Martin PhD Paloma Fernandez, PhD Javier Moratinos Ricardo Arroyo Virginia Garcia Tomas Barker BSc Marisa Delgado BSc
Preventive effect of AIT over the atopic march
Preventive effect of AIT over the atopic march Susanne Halken, Professor, Pediatric Allergist Hans Christian Andersen Children s Hospital Odense University Hospital, DK Type Disclosure In relation to this
More informationProof-of-Concept Phase-2a Clinical Trial of ANB020 (Anti-IL-33 Antibody) in the Treatment of Moderate-to-Severe Adult Atopic Dermatitis
Proof-of-Concept Phase-2a Clinical Trial of ANB020 (Anti-IL-33 Antibody) in the Treatment of Moderate-to-Severe Adult Atopic Dermatitis Professor Graham Ogg University of Oxford United Kingdom European
More informationThe European Asthma Research & Innovation Partnership tackling Europe s high asthma prevalence and death rates
The European Asthma Research & Innovation Partnership tackling Europe s high asthma prevalence and death rates Drug Delivery to the Lungs Conference, December 2016 Samantha Walker PhD, Director, Research
More informationEAACI Presentation by Wesley Burks, MD June 7, 2015 Barcelona, Spain
A Novel Characterized Peanut Allergen Formulation (AR101) for Oral Immunotherapy (OIT) Induces Desensitization in Peanut-Allergic Subjects: A Phase 2 Clinical Safety and Efficacy Study Bird JA, Spergel
More informationLION-HEART. Levosimendan Intermittent administration in Outpatients: effects on Natriuretic peptides in advanced chronic HEART failure
LION-HEART Levosimendan Intermittent administration in Outpatients: effects on Natriuretic peptides in advanced chronic HEART failure Multicentre, randomized, double-blind, parallel group, placebo-controlled
More informationEAACI Congress 2019 SCIENTIFIC PROGRAMME HIGHLIGHTS 1-5 JUNE Lisbon, Portugal
EAACI Congress 2019 SCIENTIFIC PROGRAMME HIGHLIGHTS 1-5 JUNE 2019 Lisbon, Portugal WWW.EAACI.ORG Mapping the new world of allergy" at EAACI Congress 2019 This year we will offer you an innovative scientific
More informationConcept paper on a Guideline for allergen products development in moderate to low-sized study populations
1 2 3 4 5 6 7 13 December 2018 EMA/CHMP/251023/2018 Rheumatology / Immunology Working Party (RIWP) Concept paper on a Guideline for allergen products development in moderate to low-sized study populations
More informationCOST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN)
COST ACTION CA17118 - IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN) Working group 1 management committee duties - Contribute
More informationCardiovascular Diseases (BMM9) and Getting to Know CNIC course Course
Cardiovascular Diseases (BMM9) and Getting to Know CNIC course Course 2013-2014 A. Lectures: 13-30 January (09:30-12:15 h) I. Form and function of the cardiovascular system (13-15 January) 13 January (09.30
More informationCommon and differential patterns in the inflammatory mediator release
Common and differential patterns in the inflammatory mediator release Paloma Campo MD, PhD U.G.C. Allergy Carlos Haya Hospital, Málaga- SPAIN EAACI SUMMER SCHOOL 19-21 September 2013 Málaga, Spain Disclosure
More informationANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
SECRETARÍA GENERAL DE SANIDAD DIRECCIÓN GENERAL DE SALUD PÚBLICA Y SANIDAD EXTERIOR ANONYMOUS UNLINKED STUDY OF THE PREVALENCE OF ANTI- HIV ANTIBODIES IN MOTHERS OF LIVE NEWBORNS FROM 6 AUTONOMOUS REGIONS
More informationMetabolism and metabolomics in studying human health and ageing
Metabolism and metabolomics in studying human health and ageing Dr Warwick (Rick) Dunn School of Biosciences, Phenome Centre Birmingham and Institute of Metabolism and Systems Research, University of Birmingham,
More informationCOST ACTION CA IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN)
COST ACTION CA17118 - IDENTIFYING BIOMARKERS THROUGH TRANSLATIONAL RESEARCH FOR PREVENTION AND STRATIFICATION OF COLORECTAL CANCER (TRANSCOLOCAN) Working group 1 participant duties - Align with the scientific
More informationGastrointestinal Oncology
2 nd MD ANDERSON INTERNATIONAL MEETING IN Gastrointestinal Oncology CURRENT PRACTICE AND CONTROVERSIES in the Era of Personalized Medicine e Madrid, 13 th -15 th November, 2019 SCIENTIFIC PROGRAM Meeting
More informationFood Allergy Advances in Diagnosis
22 nd World Allergy Congress Food Allergy Advances in Diagnosis By: Hugh A. Sampson, M.D. Food Allergy Advances in Diagnosis Hugh A. Sampson, M.D. Professor of Pediatrics & Immunology Dean for Translational
More informationIoana Agache Transylvania University Brasov. Precision medicine in allergy and asthma
Ioana Agache Transylvania University Brasov Precision medicine in allergy and asthma Precision medicine and precision health Personalized care based on molecular, immunologic and functional endotyping
More informationSecondary prevention of allergic disease. Dr Adam Fox United Kingdom
Secondary prevention of allergic disease Dr Adam Fox United Kingdom Disclosures Lecture fees: Danone, Mead Johnson, ALK-Abello, Stallergenes, Allergy Therapeutics Industry-sponsored grant: Danone, ALK-Abello
More informationPoster Presented at the 2014 American College of Rheumatology Annual Meeting
Poster Presented at the 2014 American College of Rheumatology Annual Meeting Anne Winkler 1 James Mossell 2 Edmund MacLaughlin 3 Drew Johnson 4 J. Timothy Harrington 5 1 Winkler Medical Practice LLC, Springfield,
More informationCenters. Austria (2), Germany (5), Belgium (1), Netherlands (1), Denmark (1), Slovenia (1)
Study CS-BM32-003 Sponsor Biomay Protocol title Phase IIb study on the safety and efficacy of BM32, a recombinant hypoallergenic vaccine for immunotherapy of grass pollen allergy Clinical trial phase Phase
More informationThe omics approach in measuring the double burden of malnutrition
IAEA Headquarter, Vienna, Austria, 3-5 October 2017 Joint IAEA-WHO-UNICEF workshop on analysis of biological pathways to better understand the double burden of malnutrition and to inform action planning
More informationBIOCRATES Life Sciences AG
BIOCRATES Life Sciences AG The Deep Phenotyping Company European Business Development Conference BIO-Deutschland, 23.-24.09.2013 Dr. Wulf Fischer-Knuppertz CEO 1 The Company Targeted Metabolomics Founded
More informationAttendance: 12 Members, 0 Community Partners, 1 Public, 5 Staff (P) present, (E) excused absence, (U) unexcused absence
Regional Community Advisory Committee (RCAC) Region 8 - San Pedro, Torrance, Wilmington - Committee Summary Providence Community Health Wellness & Activity Center 470 N. Hawaiian Avenue Wilmington, CA
More informationOUTCOMES SUMMARY REPORT
Inhaled Corticosteroids in Asthma: The Balance Between Safety and Efficacy OUTCOMES SUMMARY REPORT Live Educational Activity Series May 5, 2016 December 15, 2016 ME201520772 Grant Number: 1950 MEDA Executive
More informationINTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT
INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT madrid 22nd-23th march 2012 Course Director MODERATORS AND FACULTY PANNEL R. Larrainzar Hospital U. Infanta Leonor O. Marín Peña Hospital U. Infanta
More informationUrine Biomarkers for Prostate Cancer Detection
Urine Biomarkers for Prostate Cancer Detection Dr. Qun Lu Professor of Anatomy and Cell Biology Director, The Wooten Laboratory Brody School of Medicine Acknowledgement of Support Funding US National Institutes
More informationEffect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir
Effect of 24 Week Intensification with a CCR5-Antagonist on the Decay of the HIV-1 Latent Reservoir Laura Díaz 1, Carolina Gutiérrez 2, Carmen Page 2, Raquel Lorente 1, Beatriz Hernández-Novoa 2, Alejandro
More informationThe OncoBEAM RAS liquid biopsy experience in real-world clinical practice Frederick S. Jones, Ph.D., Global Director, Medical Scientific
The OncoBEAM RAS liquid biopsy experience in real-world clinical practice Frederick S. Jones, Ph.D., Global Director, Medical Scientific Affairs,Sysmex 2 OncoBEAM liquid biopsy: circulating tumor DNA (ctdna)
More informationPolicy of Conflict of Interest in Clinical Research
Policy of Conflict of Interest in Clinical Research The Japan Society of Hepatology Academic-industrial collaboration has been assigned as a national strategy to assist in establishing Japan as a nation
More informationCLINICAL CHARACTERISTICS AND OUTCOME OF HEART TRANSPLANT IN ADULTS WITH CONGENITAL HEART DISEASES
CLINICAL CHARACTERISTICS AND OUTCOME OF HEART TRANSPLANT IN ADULTS WITH CONGENITAL HEART DISEASES Subanalysis Spanish Registry on Heart TransplantaCon (1984 2010) Authors: Dimpna C. Albert 1 María J. Paniagua
More informationSpain Carme Pinyol Natividad Calvente Pedro Gómez Cristina Espinosa Carlos Martín Paloma González Ana Becerro de Bengoa José Vicente Galindo
Chapter name President President-Elect Past President Secretary Treasurer Director Director Director Other, non-board positions (please list if applicable) When are elections held for the Chapter Board?
More informationWorkshop: How to tackle the obesity epidemic in European children?
The way to the... Organization: Collaborating entities: Sociedad Argentina de Nutrición Workshop: How to tackle the obesity epidemic in European children? Coordinators: Angel Gil Luis Moreno Mercedes Gil-Campos
More informationASDEU Final Conference. Aula Pitaluga*, National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain. 29th-30th January 2018
ASDEU Final Conference Aula Pitaluga*, National School of Public Health, Instituto de Salud Carlos III, Madrid, Spain Monday 29th January 29th-30th January 2018 8.30 am - Registrations 9.00-9.10: Welcome
More informationUnderstanding the U.S. Preventive Services Task Force and its Conflicts of Interest Policies
1 Understanding the U.S. Preventive Services Task Force and its Conflicts of Interest Policies Quyen Ngo-Metzger, MD, MPH Scientific Director, USPSTF Program Agency for Healthcare Research and Quality
More informationClinical POLARIS:
Clinical metabolomics @ POLARIS: Exploring the potential of small molecule biomarkers in disease diagnostics Ho Ying Swan Group Leader, Metabolomics Bioprocessing Technology Institute Introduction to Metabolomics
More informationThe Deciphering Development Disorders (DDD) project: What a genomic approach can achieve
The Deciphering Development Disorders (DDD) project: What a genomic approach can achieve RCP ADVANCED MEDICINE, LONDON FEB 5 TH 2018 HELEN FIRTH DM FRCP DCH, SANGER INSTITUTE 3,000,000,000 bases in each
More informationDefining Severe Familial Hypercholesterolemia. Raul D. Santos MD, PhD Brazil
Defining Severe Familial Hypercholesterolemia Raul D. Santos MD, PhD Brazil 1 Disclosure Honoraria received for consulting, speaker and or researcher activities : Astra Zeneca, Akcea, Amgen, Biolab, Esperion,
More informationAuthor's response to reviews
Author's response to reviews Title: Hypermethylated 14-3-3-sigma and ESR1 gene promoters in serum as candidate biomarkers for the diagnosis and treatment efficacy of breast cancer metastasis Authors: Mercedes
More informationMIAMI CHILDREN S HOSPITAL POLICY AND PROCEDURE
ISSUED BY: Research PAGE: 1 of 6 REPLACES POLICY DATED: EFFECTIVE DATE: 08/09/2012 DISTRIBUTION: Departmentwide APPROVED BY: Andrews, April (SVP/CECO), BOD Audit and Compliance Committee, Perdomo, Jose
More informationCarcinoma Urotelial: La Célula Inflamatoria Clave en la Inmunoterapia Fernando López-Ríos
Carcinoma Urotelial: La Célula Inflamatoria Clave en la Inmunoterapia Fernando López-Ríos Laboratorio de Dianas Terapéuticas Hospital Universitario HM Sanchinarro Madrid, Spain Contents Background Immunotherapy
More informationWhat EU research policy can do for conditions such as chronic pain?
The EU Framework Programme for Research and Innovation HORIZON 2020 What EU research policy can do for conditions such as chronic pain? K Berkouk, PhD Deputy Head of Unit, Non-communicable diseases and
More informationNewsletter IN THIS ISSUE NEWS FROM OUR PARTNERS HIMA SAN PABLO. Capacity Building In Community. Evidence Based Practices. Scientific Highlight
March 2017 Puerto Rico Clinical and Translational Research Consortium Newsletter IN THIS ISSUE Page 2 Capacity Building In Community Page 4 Evidence Based Practices Page 6 Scientific Highlight Page 7 Annoucement
More informationPRELIMINARY PROGRAMME. 5 edition BERLIN ORGANISING SECRETARIAT
PRELIMINARY PROGRAMME th BERLIN 20-23 JUNE 2019 ORGANISING SECRETARIAT th SCIENTIFIC ORGANIZATION SPAO Sociedad de Pediatría de Andalucía Oriental y Extremadura PATRONEGE BERLIN 20-23 JUNE 2019 COMMITTEES
More informationBIOMARKERS IN FISH NUTRITION
BIOMARKERS IN FISH NUTRITION Advanced Research Initiatives for SEA BREAM Nutrition & SEA & Aquaculture BASS CASE STUDIES Jaume Pérez-Sánchez *Nutrigenomics& FishGrowthEndocrinology,IATS-CSIC, Castellón,
More informationWith the Presidency of Her Majesty the Queen Sofia
ay, 21 st 10:00-15:00 Welcome and registration. Posters set-up With the Presidency of Her Majesty the Queen Sofia 12:00-12:15 OFFICIAL OPENING 12:15-13:15 KEYNOTE LECTURE Introduced by: Jesús Ávila. Bengt
More informationLeading R&D pipeline with proven technology. Partners. Injection and drop-based allergy immunotherapy products
ALK at a glance The leading allergy immunotherapy specialist 33% of global allergy immunotherapy market Leading R&D pipeline with proven technology Strategic partnerships to globalise SLIT- tablet portfolio
More informationImmunity & Metabolism Human Microbiome Systems Nutrition. Food Bioactives Asian Consumers
INFANT HEALTH Clare Wall, PhD, Assoc. Professor, The University of Auckland, and Martin Kussmann, PhD, Professor, The Liggins Institute, The University of Auckland. Chief Scientist HVN On behalf of the
More informationSpringerBriefs in Cancer Research
SpringerBriefs in Cancer Research For further volumes: http://www.springer.com/series/10786 Natalia Aptsiauri Angel Miguel Garcia-Lora Teresa Cabrera MHC Class I Antigens In Malignant Cells Immune Escape
More informationSupplementary Material for Computer keyboard interaction as an indicator of early Parkinson s disease
Supplementary Material for Computer keyboard interaction as an indicator of early Parkinson s disease L. Giancardo 1,,*, A. Sánchez-Ferro 1-5,, T. Arroyo-Gallego 1,6, I. Butterworth 1, C. S. Mendoza 1,
More informationA precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy
A precision medicine approach to comprehensive NAFLD diagnosis via metabolomics-based liquid biopsy International Workshop on NASH Biomarkers May 5-6 2017, Washington D.C. Pablo Ortiz, MD, PhD (OWL CEO)
More informationSetting The setting was secondary care. The economic study was carried out in France.
Pharmacoeconomic assessment of specific immunotherapy versus current symptomatic treatment for allergic rhinitis and asthma in France Omnes L F, Bousquet J, Scheinmann P, Neukirch F, Jasso-Mosqueda G,
More informationAMERICAN INDIAN CHILDREN WITH ASTHMA: IMMUNOLOGIC AND GENETIC FACTORS 6/10/15
AMERICAN INDIAN CHILDREN WITH ASTHMA: IMMUNOLOGIC AND GENETIC FACTORS 6/10/15 WHAT IS ASTHMA? BRONCHO-SPASM MUSCLES IN AIRWAYS Rx: ALBUTEROL INFLAMMATION INCREASED MUCUS SWELLING IN LINING OF AIRWAYS Rx:
More informationCritical steps for circulating exosomes analyses
Critical steps for circulating exosomes analyses Héctor Peinado Selgas, PhD. Head, Microenvironment and Metastasis Group Spanish National Cancer Research Centre (CNIO) Where are we? Exosomes in liquid
More informationDietetic supplementation of docosahexaenoic acid (DHA) in non proliferative diabetic retinopathy
Dietetic supplementation of docosahexaenoic acid (DHA) in non proliferative diabetic retinopathy A prospective controlled study of macular function using microperimetry Communication presented at XXI CONGRESS
More informationMadrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd
Spanish National Cancer Research Centre CNIO Frontiers Meetings 2015 Madrid 22 25 March 2015 New Trends in Anticancer Drug Development Application deadline February 23 rd Organisers Manuel Hidalgo Alberto
More informationPeanut Allergy Desensitization
Peanut Allergy Desensitization DERRICK R. WARD, MD KANSAS CITY ALLERGY AND ASTHMA ASSOCIATES KAAP SPRING CME MEETING APRIL 24, 2015 Disclosures Speakers Bureau Teva pharmaceuticals Consultant None Research
More informationCanadian Immunization Conference 2018 Dec 4
Enveloped Virus-Like Particle (evlp) Cytomegalovirus (CMV) Vaccine is immunogenic and safe: preliminary results of a First-in-Humans Canadian Immunization Network (CIRN) Clinical Trials Network (CTN) -
More informationExpert Roundtable on Sublingual Immunotherapy
Expert Roundtable on Sublingual Immunotherapy FACULTY Linda Cox, MD Clinical Associate Professor, Nova Southeastern University Thomas Casale, MD Professor of Medicine, University of South Florida Peter
More informationINTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT
INTERNATIONAL VIIMEETING OF HIP SURGERY IN YOUNG ADULT madrid 22nd-23th march 2012 R. Larrainzar Hospital U. Infanta Leonor Madrid (spain) Course Director O. Marín Peña Hospital U. Infanta Leonor Madrid
More informationENYGO REPORT. Summary
ENYGO REPORT Summary The first ENYGO Workshop on Fertility Sparing in Gynaecological Oncology was held at La Paz University Hospital in Madrid (Spain) from 27 to 28 January 2017. It was a very successful
More informationWHO HEALTH IN PRISONS PROJECT(WHO HIPP) BEST PRACTICE AWARDS SCHEME 2009 APPLICATION FORM
WORLD HEALTH ORGANIZATION REGIONAL OFFICE FOR EUROPE ORGANISATION MONDIALE DE LA SANTÉ BUREAU RÉGIONAL DE L'EUROPE WELTGESUNDHEITSORGANISATION REGIONALBÜRO FÜR EUROPA WHO HEALTH IN PRISONS PROJECT(WHO
More informationIoana Agache Transylvania University Brasov. Challenges in the management of anaphylaxis
Ioana Agache Transylvania University Brasov Challenges in the management of anaphylaxis Outline Gaps in the evidence Anaphylaxis in community settings Anaphylaxis and precision medicine Epidemiology and
More informationSummary... 2 TRANSLATIONAL RESEARCH Tumour gene expression used to direct clinical decision-making for patients with advanced cancers...
ESMO 2016 Congress 7-11 October, 2016 Copenhagen, Denmark Table of Contents Summary... 2 TRANSLATIONAL RESEARCH... 3 Tumour gene expression used to direct clinical decision-making for patients with advanced
More informationProteome analysis Cellular proteomics Plasma proteomics
Proteome analysis Cellular proteomics Plasma proteomics Janne Lehtiö Maria Pernemalm Karolinska Biomics Center Karolinska Institutet / Karolinska University Hospital Janne Lehtio 2009-02-09 1 KBC Proteomics
More informationDNA methylation and a biomarker panel to predict asthma development
Accepted Manuscript DNA methylation and a biomarker panel to predict asthma development Harald Renz, MD PII: S0091-6749(19)30483-X DOI: https://doi.org/10.1016/j.jaci.2019.04.002 Reference: YMAI 13961
More informationSLIT: Review and Update
SLIT: Review and Update Disclosure Speaker: ISTA Pharmaceuticals Speaker: GlaxoSmithKline Allergen IT - Evidence Based Evaluation: Rescue Medications Meta-analysis Disease IT # of Patients Rescue Medication
More informationAllergens: Science, Health Effects and Innovations
Allergens: Science, Health Effects and Innovations September 26 th -27 th 2017, Indoor Biotechnologies, Cardiff, UK Speaker profiles Matthew Perzanowski PhD Associate Professor Environmental Health Sciences
More informationINOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY
INOVIO PHARMACEUTICALS, INC. INVESTIGATOR CONFLICT OF INTEREST POLICY August 24, 2012 1. Purpose Public confidence and the reputation of the company are valuable business assets that Inovio strives to
More informationThursday, September 11
WORKING AGENDA INTERNATIONAL CLINICAL TRIAL WORKSHOP September 11-13 2014 Hotel Sheraton L Sierr Saloon, Córdoba, Argentina Chairs: Lucia Delgado, Guadalupe Pallota, Eduardo Richardet Thursday, September
More informationControversies in the Diagnosis of Type 1 VWD. Paula James MD, FRCPC ISLH Honolulu, Hawaii Friday, May 5, 2017
Controversies in the Diagnosis of Type 1 VWD Paula James MD, FRCPC ISLH Honolulu, Hawaii Friday, May 5, 2017 Disclosures for Paula James Research Support/P.I. Employee Consultant Major Stockholder Speakers
More informationOBJECTIVES OF THE MEETING
OBJECTIVES OF THE MEETING The Second European LAM Conference is an international meeting with the purpose of getting insights into the new results of research and sharing with patient s community and educational
More informationIs there an allergy epidemic and what are the possible causes?
Is there an allergy epidemic and what are the possible causes? Professor Michael Gold Department of Allergy and Immunology Women s and Children s Health Network Discipline of Paediatrics University of
More informationOccupation-related differences in the prevalence of metabolic syndrome
Diabetes Care Publish Ahead of Print, published online June 20, 2008 Metabolic syndrome in workers Occupation-related differences in the prevalence of metabolic syndrome Miguel Angel Sánchez-Chaparro a,b,
More informationSEPTUA The Seven Wonders of the Shoulder
SEPTUA The Seven Wonders of the Shoulder Symposium Preliminary Programme Chairperson: Miguel Angel Ruiz Ibán, (ES) NH Manzanares, Madrid, Spain 28 29 October, 2016 Description The symposium will bring
More information26 November Lima, Perù
PRELIMINARY PROGRAMME 2014 Pre LACTRIMS conference on progressive MS 26 November 2014 - Lima, Perù Dear participant, A warm welcome to all attending the 2014 Pre LACTRIMS conference on progressive MS.
More informationAre Payers Getting Tougher? Essential Insights on How to Smooth Acceptance of New Genetic Tests
Are Payers Getting Tougher? Essential Insights on How to Smooth Acceptance of New Genetic Tests Jacqueline Huang Senior Associate Reimbursement Policy and Government Affairs Objectives Learn how payers
More informationRDP Cores Highlights: the CF Analytics Core. Facundo M. Fernández School of Chemistry and Biochemistry Georgia Institute of Technology
CF@LANTA RDP Cores Highlights: the CF Analytics Core Facundo M. Fernández School of Chemistry and Biochemistry Georgia Institute of Technology CF@LANTA RDP Center The CF@LANTA RDP Center at Emory University
More informationDisclosure Slide. Example 1:
Resolving Conflicts in CME George C. Mejicano, MD, MS Professor of Medicine Senior Associate Dean for Education Disclosure Slide Dr. Mejicano has no personal financial relationships with commercial interests
More informationThe 8th National Gastric Cancer Academic Conference: focus on specification, translational research, and plan
Meeting Report The 8th National Gastric Cancer Academic Conference: focus on specification, translational research, and plan Ni Dai Beijing Cancer Hospital and Institute, Peking University School of Oncology,
More informationTitle: Experimental evaluation of a parent-implemented AAC intervention protocol for children with severe autism
Title: Experimental evaluation of a parent-implemented AAC intervention protocol for children with severe autism 60min interactive workshop Long Abstract Declaration of Interest Statement The authors disclose
More informationAccelerated Immunotherapy Schedules: More Convenient? Just As Safe?
Accelerated Immunotherapy Schedules: More Convenient? Just As Safe? David A. Khan, MD Professor of Medicine Allergy & Immunology Training Program Director Division of Allergy & Immunology University of
More informationAllergen Analysis : Customer Solution Case Studies. ILSI Madrid 2018 Adrian Rogers
Allergen Analysis : Customer Solution Case Studies ILSI Madrid 2018 Adrian Rogers Immunoassay Challenges Every food is different and presents it s own unique challenges with immunoassay analysis If there
More informationThe Future of Allergy Treatment Ultra-Fast Allergy Immunotherapy
The Future of Allergy Treatment Ultra-Fast Allergy Immunotherapy 1 Anergis Focus on Allergy Immunotherapy (AIT) High Medical Need and Patient Demand 500 M allergic patients - fastest growing chronic condition
More information21-23 CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS CONGRESS
IV CONGRESO INTERNACIONAL DE INVESTIGACIÓN E INNOVACIÓN EN ENFERMEDADES NEURODEGENERATIVAS IV INTERNATIONAL ON RESEARCH AND INNOVATION IN IVNEURODEGENERATIVE DISEASES IV CONGRESS ALICANTE 2016 Septiembre
More informationACCURATE DIAGNOSIS OF ALLERGIC AIRWAY DISEASES
DEPARTMENT OF OTORHINOLARYNGOLOGY UPPER AIRWAYS RESEARCH LABORATORY ACCURATE DIAGNOSIS OF ALLERGIC AIRWAY DISEASES Prof Dr Philippe GEVAERT DISCLOSURES Phillipe Gevaert, MD, PhD, has disclosed the following
More informationKDIGO Conference San Francisco March KDIGO. Mechanisms of drug hypersensitivity. A. J. Bircher Dermatology/Allergology
Conference San Francisco March 27 30 2014 Mechanisms of drug hypersensitivity A. J. Bircher Dermatology/Allergology University Hospital Basel Switzerland andreas.bircher@unibas.ch Disclosure of Interests
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More informationDefining Asthma: Bronchial Hyperresponsiveness. Defining Asthma: Clinical Criteria. Impaired Ventilation in Asthma. Dynamic Imaging of Asthma
Defining Asthma: Clinical Criteria Defining Asthma: Bronchial Hyperresponsiveness Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine,
More informationPOSITION DESCRIPTION. Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) PURPOSE OF POSITION DESCRIPTION
POSITION DESCRIPTION Position Title: Location: Research Coordinator Clinical Trials National Secretariat, Brisbane-based Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) Reporting Relationships:
More informationIMMUNOLOGIC CHANGES IN ALZHEIMER CAREGIVERS. Janice Kiecolt-Glaser; Ph.D. Introduction
IMMUNOLOGIC CHANGES IN ALZHEIMER CAREGIVERS Janice Kiecolt-Glaser; Ph.D. Introduction Thus far, the presentations have focused on individuals with specific diseases in revealing a link between psychological
More informationHypersensitivity Reactions and Peanut Component Testing 4/17/ Mayo Foundation for Medical Education and Research. All rights reserved.
1 Hello everyone. My name is Melissa Snyder, and I am the director of the Antibody Immunology Lab at the Mayo Clinic in Rochester, MN. I m so glad you are able to join me for a brief discussion about the
More informationPodcast/MP3 Instructions 1. Download the Podcast or MP3 audio file to your player. 2. Listen to the presentation. 3. To receive continuing education
Podcast/MP3 Instructions 1. Download the Podcast or MP3 audio file to your player. 2. Listen to the presentation. 3. To receive continuing education credit, use the link to the online test or print the
More informationTHE SEARCH FOR BIOMARKERS IN BLADDER CANCER
THE SEARCH FOR BIOMARKERS IN BLADDER CANCER CDDP and IO WORLD ALEJO RODRÍGUEZ-VIDA MD PhD Consultant Medical Oncologist Associate Professor Hospital del Mar, Barcelona November 23 rd 2018 DISCLOSURE OF
More informationTowards Precision Medicine in Inflammatory Bowel Diseases
Precision Medicine and Biomarkers Leaders Summit. Munich September 13-14, 2018 Towards Precision Medicine in Inflammatory Bowel Diseases ANDRÉS HURTADO-LORENZO, Ph.D. SENIOR DIRECTOR OF TRANSLATIONAL RESEARCH
More informationDOWNLOAD OR READ : UPDATE ON BIOMARKERS IN ASTHMA AN ISSUE OF IMMUNOLOGY AND ALLERGY CLINICS PDF EBOOK EPUB MOBI
DOWNLOAD OR READ : UPDATE ON BIOMARKERS IN ASTHMA AN ISSUE OF IMMUNOLOGY AND ALLERGY CLINICS PDF EBOOK EPUB MOBI Page 1 Page 2 update on biomarkers in asthma an issue of immunology and allergy clinics
More informationDay 0 Sunday, July 8: Arrivals. Day 1 Monday, July 9: Introduction, Fundamentals, and Germline Variation. *As of 6/29/18
AACR Integrative Molecular Epidemiology Workshop: Bridging Cancer Biology and Precision Medicine July 9-13, 2018 (*arrival July 8) Westin Copley Place, Boston Boston, Massachusetts *As of 6/29/18 Director:
More informationQuality Controls in Allergy Diagnosis
Quality Controls in Allergy Diagnosis Alistair Crockard Royal Hospitals Belfast Northern Ireland Quality Controls in Allergy What do we want? Diagnosis What can be controlled? What can be achieved? What
More informationLyme Disease Diagnosed by Alternative Methods and Similar Syndromes: Research Approaches to Take us Forward
Lyme Disease Diagnosed by Alternative Methods and Similar Syndromes: Research Approaches to Take us Forward David M. Patrick University of British Columbia, Vancouver, Canada 2016 David Patrick, MD 1 Disclosures
More informationELECTIONS APPLICATION FORM WPHNA Executive Committee
ELECTIONS 2017 APPLICATION FORM WPHNA Executive Committee This is the Application form for the 2017 WPHNA Elections. All queries about positions, the election process, or any other relevant matter, should
More informationDefining Asthma: Clinical Criteria. Defining Asthma: Bronchial Hyperresponsiveness
Defining Asthma: Clinical Criteria Atopy 34% Recent wheeze 20% Asthma 11% AHR 19% n = 807 From: Woolcock, AJ. Asthma in Textbook of Respiratory Medicine, 2nd ed. Murray, Nadel, eds.(saunders:philadelphia)
More information